A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Patients who participated in the core EPO2121 study and did not clinically progress may
participate in this extension protocol to further evaluate the safety, tolerability, and
efficacy of patupilone.